subperiosteal implants
Analysis of HA-coated subperiosteal implants
- 29 March 2003
- Posted by: anjaform
- Category: Clinical Studies and Case Reports
John C. Minichetti
Full text link: https://pubmed.ncbi.nlm.nih.gov/12837050/
Analysis of HA-coated subperiosteal implants
1. Scientific Reference
- Study Title: Analysis of HA-coated subperiosteal implants
- Author: John C. Minichetti
- Journal: Journal of Oral Implantology
- Publication Year: 2003
- DOI: 10.1563/1548-1336(2003)029<0111>2.3.CO;2
2. Scientific Background
Managing severe alveolar bone atrophy in edentulous patients remains one of the most challenging aspects of implant dentistry. As bone grafting and augmentation procedures became increasingly adopted in clinical practice, the use of subperiosteal implants gradually declined. According to the author, this shift has been accompanied by a reduction in both scientific publications and academic interest dedicated to this treatment modality.
Against this background, the present study revisits hydroxyapatite-coated subperiosteal implants as a prosthetic support option for patients with advanced bone deficiency. Rather than introducing a new surgical concept, the investigation documents the clinical performance of this implant design over an extended period while exploring how treatment characteristics may differ according to the type of dental arch and the extent of implant reconstruction.
3. Study Objective
The primary objective of this study was to evaluate the clinical success and complication rates associated with 22 hydroxyapatite-coated subperiosteal implants placed over a ten-year period. In addition, the author investigated possible relationships between the treated arch and the use of either full-arch or unilateral subperiosteal implant designs. No additional study objectives are specified in the available abstract.
4. Methodology
Based on the available information, this publication appears to describe a clinical case series involving hydroxyapatite-coated subperiosteal implants.
The analysis includes 22 implants placed during a 10-year period. Clinical evaluation focused on implant success and treatment-related complications. The study also examined potential correlations between the anatomical arch treated and whether patients received a complete or unilateral subperiosteal implant framework.
The abstract does not specify the number of patients included, inclusion criteria, follow-up duration for individual cases, statistical methods, outcome definitions, or detailed assessment protocols. These methodological details are therefore unavailable from the information provided.
5. Main Findings
The abstract indicates that the study reports both the success rates and the complication rates observed among the 22 hydroxyapatite-coated subperiosteal implants included in the analysis. It also states that relationships between arch type and the use of complete versus unilateral subperiosteal implant designs were evaluated.
However, the abstract does not provide numerical outcomes, statistical analyses, survival rates, complication frequencies, or comparative results. Consequently, it is not possible to quantify the reported clinical performance or determine whether significant differences were identified between the treatment configurations assessed.
6. Clinical Interpretation
This publication is noteworthy because it revisits a treatment approach that had become progressively less prominent as bone augmentation procedures gained wider acceptance in implant dentistry. By documenting a decade of clinical experience, the study contributes additional information regarding the use of hydroxyapatite-coated subperiosteal implants for prosthetic rehabilitation in patients affected by substantial bone atrophy.
Although the investigation emphasizes clinical success and complications, the limited information available in the abstract prevents a comprehensive evaluation of treatment predictability or long-term effectiveness. Likewise, the study should not be interpreted as demonstrating superiority over conventional endosseous implants, bone grafting procedures, or alternative reconstructive techniques, since no such comparisons are presented.
From a clinical perspective, the publication highlights continued interest in subperiosteal implant therapy within selected patient populations while underscoring the need for cautious interpretation because detailed outcome data are not available in the published abstract.
7. Clinical Applications
The study is relevant to the prosthetic rehabilitation of edentulous patients with significant alveolar bone atrophy, where conventional implant placement may be challenging.
Its findings contribute to the body of evidence describing hydroxyapatite-coated subperiosteal implants as a treatment option for prosthetic stabilization in this clinical setting.
However, the available information does not define patient selection criteria, surgical indications, contraindications, or comparative clinical advantages. Therefore, no specific treatment recommendations can be drawn solely from the abstract.
8. Level of Evidence, Limitations, and Transparency
Based on the available information, this publication most likely represents a clinical case series, corresponding to a relatively low level of clinical evidence compared with randomized controlled trials or systematic reviews.
Several methodological limitations are evident from the abstract itself. Important information—including patient demographics, follow-up protocols, outcome definitions, statistical analyses, and detailed clinical results—is not reported. Furthermore, no control group is mentioned.
The available abstract does not disclose any conflicts of interest, financial support, or relationships with implant manufacturers.
Accordingly, the reported findings should be interpreted with appropriate caution given the limited methodological information currently available.
9. Key Study Highlights
- Study design: Probable clinical case series
- Level of evidence: Low to moderate
- Study population: Not specified in the available abstract
- Number of implants: 22 hydroxyapatite-coated subperiosteal implants
- Observation period: Implants placed over a 10-year period; individual follow-up duration not specified
- Primary outcome: Clinical success and complications
- Main findings: Success and complication rates were analyzed; numerical results are not reported in the available abstract
- Scientific conclusion: The study evaluates the clinical performance of hydroxyapatite-coated subperiosteal implants and examines associations between implant configuration and arch type.
- Main limitations: Limited methodological information and absence of quantitative outcome data in the abstract.
10. Scientific Impact
This study contributes to the literature by documenting clinical experience with a treatment modality that was becoming less frequently reported as reconstructive bone augmentation gained wider clinical acceptance. Rather than introducing new evidence supporting a change in clinical practice, it preserves valuable information regarding the use of hydroxyapatite-coated subperiosteal implants in patients presenting with advanced alveolar bone loss.
Its scientific value lies primarily in expanding the clinical documentation of this implant design and encouraging continued evaluation of its outcomes. Because the abstract provides only limited methodological and quantitative information, the study should be regarded as descriptive rather than definitive. Additional investigations with more comprehensive reporting and higher levels of evidence would be necessary to clarify the long-term clinical role of this therapeutic approach.
11. Editorial Conclusion
This publication presents a clinical evaluation of 22 hydroxyapatite-coated subperiosteal implants placed over a ten-year period, focusing on treatment success, complications, and implant configuration. Although the study contributes to the historical and clinical literature surrounding subperiosteal implant rehabilitation, the limited information contained in the available abstract does not allow detailed assessment of clinical performance. Consequently, its findings should be interpreted as descriptive evidence requiring confirmation through more comprehensive clinical investigations.
